4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MiMedx Group, Inc. (MDXG) operates in the Biotechnology industry and is headquartered in Marietta, United States with about 808 employees. Its market capitalization is roughly $640 million. In the fiscal year ended 2025-12-31, MDXG reported $419M in revenue and $49M in net income.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Interactive charts & full statements → Open the MDXG valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $419M | $349M | $322M | $268M | — |
| Gross Profit | $346M | $289M | $267M | $220M | — |
| Operating Income (EBIT) | $64M | $59M | $37M | ($15M) | — |
| Net Income | $49M | $42M | $58M | ($30M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $59M | $118M | $114M | $99M | $88M | — |
| Gross Profit | $42M | $99M | $95M | $80M | $72M | — |
| Operating Income (EBIT) | ($16M) | $21M | $22M | $12M | $8M | — |
| Net Income | ($11M) | $15M | $17M | $10M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $343M | $264M | $239M | $171M | — |
| Total Liabilities | $86M | $71M | $96M | $189M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDXG viewer.
About TickerBase · Data methodology & sources